Lennart Spindler, PhD is an Associate at SV Health Investors on the Dementia Discovery Fund (DDF) team, the world's largest family of specialised venture capital funds investing exclusively in companies developing or enabling novel therapeutics for dementia. Deeply committed to addressing this largest unmet medical need of our time, Lennart builds on both previous investment experience (Cambridge Enterprise, Start Codon, Syncona) and on translational neuroscience expertise (PhD and Postdoc Clinical Neurosciences, University of Cambridge), having worked widely along the ideas-to-assets lifecylce, across assay development all the way to clinical trials.